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Abstract
Teenage binge drinking is a major health issue; however, there is a paucity of data on liver injury. Herein, we investigated how acute ethanol 
affects juvenile hepatic cells through changes in oxidative stress, apoptosis, and liver function, as well as the ability of betaine, which can replen-
ish the antioxidant glutathione and mitigate oxidative injury. Juvenile male Wistar rats were given either water or betaine (2% w/v) for 6 days 
and treated with either saline 0.15 mol/L NaCl or ethanol (75 mmol/kg bodyweight). After 24 h, liver enzymes, oxidative damage, apoptosis, and 
parameters of antioxidant enzyme activity were examined. Acute ethanol increased hepatic enzymes (99%, P < 0.05). Total protein and albumin 
levels were reduced by 14 and 18% (P < 0.001), respectively, which was prevented by betaine treatment. Cytosolic cytochrome c increased by 
59% (P < 0.05), corresponding to a decrease in mitochondrial cytochrome c content, which was ameliorated with betaine. Cytosolic glutathione 
peroxidase was reduced with alcohol (P < 0.05) and was prevented with betaine. Subtle changes were observed in catalase, superoxide dismutase, 
glutathione reductase, and complex I activity after ethanol treatment. In summary, whilst juvenile animals appear to have higher basal levels of 
antioxidant enzymes, betaine conferred some protection against alcohol-induced oxidative stress.
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Introduction
Worldwide, alcoholic liver disease (ALD) is a major cause of 
chronic liver disease, which develops due to excessive, pro-
longed consumption of alcohol. This results in the formation 
of fatty liver, which can develop to steatohepatitis, cirrhosis/
fibrosis, and lastly hepatocellular cancer (1).
ALD is traditionally associated with the adult population; 
however, recent statistical reports have identified an alarm-
ing increase in the percentage of teenage binge drinking. The 
proportion of adolescents who binge drink remains high 
with a shift toward young people drinking more frequently 
with the intention of becoming intoxicated (2). Adolescents 
are now exposing their livers to the damaging effects of eth-
anol more frequently and more seriously than at any time in 
the past. The United Kingdom, in particular, is consistently 
categorized as a high prevalence country for underage drink-
ing (3), with a third of British teenagers reporting intoxi-
cation by the age of 13 (4). The National Survey on Drug 
Use and Health has estimated that in the United States 22% 
of adolescents used alcohol in 2016 (5), whereas the Euro-
pean School Survey Project on Alcohol and Other Drugs has 
revealed that at least half  of the students in three-quarters 
of the countries surveyed had drunk an alcoholic beverage 
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day, animals were i.p. treated with either saline or ethanol. 
Following treatment, food was removed, and the rats were 
sacrificed 24 h later. Hepatic cytosol and mitochondria were 
prepared as previously described (24). Blood serum was col-
lected and stored for subsequent liver function test analysis. 
Liver function tests were measured by standard laboratory 
diagnostic procedures as previously described (25).
Glutathione levels
GSH levels were determined using an assay adapted from 
Tietze (26) based on the conversion of 5’5’-dithio-bis-2- 
(nitrobenzoic acid) (DNTB) to 5-thio-2-nitrobenzoic acid 
(TNB) by glutathione reductase (GR). Cytosolic or mito-
chondrial protein (5 µL) was added to the reaction buffer 
(100 mM sodium phosphate, 1 mM EDTA, 0.5 mM DTNB, 
0.175 mM NADPH, 1.7U/mL GR) and the absorbance mea-
sured at 412 nm for 25 min.
Malondialdehyde levels
Malondialdehyde (MDA) levels were detected using a col-
orimetric thiobarbituric acid reactive substances assay 
adapted from Bar-Or et al (27). Protein (500 µg) was mixed 
with 400  µL of 20 mM phosphate buffer (pH 7.4) and 
500 µL reaction buffer (5 mg/mL thiobarbituric acid, 25 mM 
NaOH, 50% glacial acetic acid). Samples were tightly sealed 
and boiled for 1 h, rested on ice for 10 min, and the absor-
bance measured at 532 nM.
Cytochrome c levels
The expression of Cytochrome c protein was quantified by 
an immunoblotting technique. Protein (60 µg cytosol or 40 µg 
mitochondria) was loaded onto gels and following transfer, 
the membranes were incubated with mouse anti-cytochrome c 
(1:1000) overnight, followed by the secondary antibody rab-
bit anti-mouse (1:10,000). Signals were detected using Pierce 
ECL reagent (Thermofisher, UK). The resultant images were 
analyzed using the Biorad GS-800 Calibrated Densitometer.
Caspase-3 activity
Caspase-3 activity was evaluated by measuring the flu-
orescence of N-Acetyl-Asp-Glu-Val-Asp-7-amido-4- 
trifluoromethylcoumarin (Ac-DEVD-AFC) after cleavage 
by caspase-3 to 7-amino-4-trifluoromethyl-coumarin (AFC) 
following incubation with 25 µg of protein. Samples (10 μL) 
were incubated in darkness with 100 μL of the substrate solu-
tion (10 µg/mL Ac-DEVD-AFC, 100 mM HEPES, 10 mM 
DTT) for 1 h at 37°C. The fluorescence was measured using 
an excitation wavelength of 380 nm and emission wavelength 
of 520 nm (28).
at age 13 or younger (3, 4). Whilst the clinical consequences 
of ethanol intake have been studied in adults, it remains 
unclear as to whether adolescents are more susceptible to 
ethanol-mediated liver damage, or if  they can withstand the 
adverse effects better than adults. Animal studies with binge 
ethanol treatment have shown to decrease adenosine triphos-
phate (ATP) production as well as increase reactive oxygen 
species (ROS) and mitochondrial dysfunction, thus altering 
the electron transport chain components, resulting in mito-
chondrial failure (6–8).
Antioxidant enzymes are capable of catalyzing the decom-
position of ROS (9). The three main antioxidant enzymes are 
superoxide dismutase (SOD), which can protect against toxic 
effects of superoxide radicals (10); glutathione peroxidase 
(GPx), which protects against oxidative injury (11); and cat-
alase, which promotes the breakdown of hydrogen peroxide 
H2O2 (11).
The use of antioxidants serves as a prospective therapeutic 
approach for the treatment of ALD. Glutathione (GSH) is an 
intracellular antioxidant, which can neutralize basal levels of 
ROS (12). Other nutrients such as betaine play a role in the 
cysteine production pathway (13), ultimately forming GSH. 
Recent chronic experimental studies have examined the pro-
tective effects of betaine against alcohol-induced liver damage 
(14–18). In animal studies, dietary betaine has been shown to 
ameliorate the adverse effects of acute (19) and chronic etha-
nol dosing on liver steatosis and oxidative stress (20–23).
However, there are few studies exploring the effect of eth-
anol intoxication in the teenage population. Therefore, we 
aimed to investigate how ethanol affects hepatic cells through 
changes in oxidative damage, apoptosis, and liver function in 
juvenile rats. The effects of betaine supplementation on eth-
anol-induced injury in very young animal models is also lim-
ited. The use of betaine will determine if  any such damage 
(and by extension, protection) is mediated through oxidative 
damage and the antioxidant capacity of the liver.
Materials and Methods
Animals
Juvenile male Wistar rats (50–55 g) were obtained from 
Charles Rivers (Bicester, UK) and housed according to 
good laboratory practice guidelines at the Biological Ser-
vices Unit at Kings College, London. Animals were age and 
weight matched and divided into four groups: (1) Control, 
i.p. treated 0.15 mol/L NaCl; (2) Ethanol, i.p. treated ethanol 
(75 mmol/kg bodyweight); (3) Betaine 2% (w/v) in drinking 
water and i.p. treated 0.15 mol/L NaCl; and (4) Betaine (2% 
w/v) in drinking water and i.p. treated ethanol (75 mmol/kg 
bodyweight). Groups 1 and 2 were given water for 1 week 
and groups 3 and 4 received free access to food and freshly 
prepared betaine (2% w/v) in the drinking water. On the 7th 
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Results
Food, water, and body parameters
For the period of betaine treatment, food, water consump-
tion, and body weights were recorded (Table 1). Betaine had 
no effect on food or water intake in the 6 days preceding the 
ethanol treatment, and body weights were also unchanged on 
the final day. On the other hand, liver weights were increased 
by 13 and 17% (P < 0.05), respectively, in the ethanol and 
betaine-/ethanol-treated groups, when compared to their 
corresponding controls. The ratio of liver weight to body 
weight was used to account for any differences in individual 
rat weights and liver sizes. A slight increase was observed in 
the liver weight/body weight ratio in ethanol-treated animals 
when compared to their corresponding control. In the etha-
nol group, a slight increase of 6% was observed, while there 
was a 5% increase in the betaine plus ethanol group, with the 
latter significantly increasing by 12% when compared to con-
trol animals (P < 0.01) (Table 1).
Liver function
Following ethanol treatment, ALT levels increased by 99% 
(P < 0.05) and AST levels showed an increase of 10% (Table 
2). Although betaine alone showed no effect, betaine fol-
lowed by ethanol led to an increase of 160% (P < 0.001) in 
ALT levels and 82% (P < 0.05) in AST levels. Following eth-
anol treatment, the AST/ALT value decreased by 41% (P < 
0.001), and decreased by 32% (P < 0.001) following betaine 
and ethanol treatment. Total protein and albumin levels were 
also reduced following ethanol treatment by 14% (P < 0.001) 
and 18% (P < 0.001), respectively. However, this decrease 
was completely prevented in the betaine and ethanol group 
when compared to both control and betaine-alone treatment 
groups. There were no changes in circulating globulin levels 
in all treatment groups (Table 2).
Complex I activity
The Complex I Enzyme Activity Microplate Assay Kit 
(Abcam, UK) was used to determine the activity of mito-
chondrial OXPHOS Complex I in the electron transport 
chain. Assay solution was prepared with 40 mM NADH. 
This method determined whether treatment of cells causes 
damage at complex I. Absorbance was read at OD 450 nm.
Antioxidant enzyme activity
The Glutathione Peroxidase Cellular Activity Assay Kit 
(Sigma, UK) was used as an indirect determination method 
based on the oxidation of GSH to GSSG. The decrease in 
NADPH absorbance was measured at 340 nm, indicating 
GPx activity. Glutathione Reductase Assay Kit (Sigma, UK) 
was used to measure the activity of GR, analyzed by spec-
trophotometric measurement. The activity was measured 
by any increase in absorbance caused by the reduction of 
DTNB at 412 nm. The Catalase Assay Kit (Abcam, UK) was 
used to measure catalase activity. Unconverted H2O2 reacts 
with OxiRedTM probe, which was analyzed by spectropho-
tometric measurement at 570 nm. The SOD Assay Kit-WST 
(Sigma, UK) was used to measure the activity of SOD via 
the utilization of Dojindo’s highly water-soluble tetrazolium 
salt, WST-1 (2-(4-Iodophenyl)- 3-(4-nitrophenyl)-5-(2,4-di-
sulfophenyl)- 2H-tetrazolium,monosodium salt) that pro-
duces a water-soluble formazan dye upon reduction with a 
superoxide anion. SOD activity was measured spectrophoto-
metrically at 440 nm.
Statistical analysis
Results were analyzed using a one-way ANOVA. Data are 
presented as mean + SEM (n = 3–8) and P < 0.05 was con-
sidered statistically significant.
Table 1: The effect of betaine on food and water intake, body weights, and liver weights.
Control Ethanol Betaine Betaine + Ethanol
Food intake (g/ rat/ day) 12.2 ± 0.4 11.8 ± 0.6 11.0 ± 0.4 10.7 ± 0.4
Water intake preinjections (mL/rat/day) 21.7 ± 1.1 21.4 ± 1.2 24.1 ± 1.6 21.9 ± 1.6
Water intake (post-injections (mL/rat/day) 20.5 ± 1.4 20.0 ± 1.6 16.5 ± 1.9* 17.5 ± 1.3*
Final body weight (g) 72.8 ± 1.6 77.3 ± 2.4 69.8 ± 1.6 75.6 ± 2.1
Liver weight (g) 2.67 ± 0.0 3.01 ± 0.1 2.69 ± 0.1 3.15 ± 0.2*
Liver weight (g)/body weight (kg) 36.6 ± 0.3 39.0 ± 0.8 38.4 ± 1.0 41.5 ± 1.0**
During the pretreatment stage, animals were housed in groups in cages and both food and water intake was monitored 
daily. During the treatment, animals were caged singly, deprived of food but allowed free access to water (either control or 
supplemented with 2% betaine). The body weights were recorded on the morning of sacrifice and the liver weights were 
recorded as soon as they were excised. *P < 0.05, **P < 0.01 compared to overall control.
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Apoptosis
Ethanol exposure led to a significant increase (59%; P < 0.05) 
in cytosolic cytochrome c levels in comparison to controls. 
However, cytochrome c release was prevented by betaine pre-
treatment followed by ethanol (6% decrease) (Figure 1B–C). 
In the mitochondria, a contrasting pattern occurred fol-
lowing ethanol treatment, whereby cytochrome c levels 
were lower (18%), confirming the release into the cytosol. 
Similarly, there was no change in the betaine-alone or beta-
ine-ethanol exposed groups (Figure 1).
Caspase-3 is one of the final effector caspases in the 
apoptosis pathway (along with caspase-6 and caspase-7). 
Therefore, caspase-3 levels were assayed to determine if  the 
cytochrome c release into the cytosol resulted in apoptosis 
and if  betaine could prevent this release. However, ethanol 
treatment alone led to a 19% decrease in caspase-3 activity. 
No changes were observed in either betaine alone or betaine 
followed by ethanol groups (Figure 1D).
Oxidative damage
GSH levels were generally increased in ethanol and betaine 
supplementation. Ethanol treatment and betaine supplemen-
tation alone led to a 23 and 31% increase in cytosolic GSH 
levels, respectively (Figure 2A). A similar pattern occurred 
with mitochondrial GSH levels where ethanol caused an 
increase of 22% in mitochondrial GSH levels, and betaine 
followed by ethanol resulted in a 24% increase (Figure 2B). 
To assess whether betaine supplementation provided oxi-
dative protective properties to the liver, MDA levels were 
assessed as a parameter for lipid peroxidation. Surpris-
ingly, ethanol treatment led to a 50% reduction in cytosolic 
MDA levels (P < 0.05). Betaine alone had little effect (13% 
decrease), whereas betaine followed by ethanol caused a 22% 
reduction (Figure 2C). In the mitochondria, ethanol caused 
a 47% increase in MDA formation (Figure 2D). Betaine 
alone as well as the betaine and ethanol group also showed 
no changes.
Antioxidant enzyme activity
Ethanol exposure alone led to a 31% decrease (P < 0.05) in cyto-
solic GPx activity when compared to the control (Figure 3A). 
Both the betaine only and ethanol- and betaine-treated groups 
led to a 10% and an 8% decrease, respectively, when compared 
to the corresponding controls (Figure 3B). In the mitochondria, 
no changes were seen in the ethanol and betaine-only groups. 
However, in the ethanol- and betaine-treated group, a 16% 
increase was observed (Figure 3B). GR catalyzes the reduc-
tion of GSSG to reduced GSH. In the cytoplasm, no changes 
were observed in GR activity in any treatment group (Figure 
3C). On the other hand, in the mitochondria, GR was increased 
by 175 and 575% following treatment with ethanol and beta-
ine supplementation, respectively (Figure 3D). In the ethanol- 
and betaine-treated group, a 15% reduction was observed when 
compared to the betaine only group (Figure 3D).
In the cytoplasm, ethanol treatment alone led to a 14% 
decrease in SOD activity, whereas in contrast, betaine treat-
ment alone led to a 34% increase (Figure 4A). Ethanol and 
betaine treatment led to a 53% reduction in SOD activ-
ity in the cytoplasm when compared to the betaine control 
 (Figure 4A). In the mitochondria, no changes to SOD activ-
ity were observed across all treatment groups (Figure 4B). 
The activity of catalase was also measured to assess its func-
tion. No changes in catalase activity were observed in either 
the ethanol alone, betaine alone, or a combination of etha-
nol and betaine treatments (Figure 4C).
Ethanol treatment alone led to a 50% increase in com-
plex  I activity and betaine supplementation alone led to a 
13% decrease in complex I activity, respectively (Figure 4D). 
Betaine treatment followed by ethanol led to a 43% increase 
in complex I activity when compared to the betaine only 
group (Figure 4D).
Table 2: The effect of ethanol and betaine on liver function.
Treatment ALT (U/L) AST (U/L) AST/ALT Total Protein (g/L) Albumin (g/L) Globulin (g/L)
Control 59.7 ± 5.6 382 ± 43 6.4 ± 0.5 54.0 ± 1.3 36.3 ± 0.8 17.7 ± 0.6
Ethanol 119 ± 15* 423 ± 34 3.8 ± 0.2*** 46.5 ± 1.4** 29.6 ± 0.9*** 16.9 ± 0.7
Betaine 51.8 ± 2.3 313 ± 26 6.0 ± 0.3 52.3 ± 0.9 35.0 ± 0.7 17.3 ± 0.3
Betaine/Ethanol 135 ± 4.2*** 569 ± 37* 4.1 ± 0.2*** 52.3 ± 1.8 33.7 ± 0.9 18.6 ± 0.9
The betaine-supplemented experimental animals were given drinking water containing 2% betaine (w/v) for 6 days. Saline (0.15 
mol/L NaCl) or ethanol (75 mmol/ kg bodyweight) was administered i.p. on day 7, and 24 h later the animals were sacrificed. 
Serum was analyzed by standard biochemistry tests. ALT = alanine aminotransferase; AST = aspartate aminotransferase. 
Values are mean ± SEM (n = 5–8). *P < 0.05; **P < 0.01; ***P < 0.001 compared to relevant control values.
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Figure 1: The effect of betaine on ethanol-induced changes in (A) cytosolic and mitochondrial cytochrome c detection, (B) cyto-
solic cytochrome c levels, (C) mitochondrial cytochrome c levels, and (D) caspase-3 activity. Cytochrome c levels were detected 
by Western blotting. Lanes 1–3 = control; Lanes 4–7 = ethanol; Lanes 8–10 = betaine; Lanes 11–13 = betaine and ethanol. 
Caspase-3 activity in 25 µg of cytosolic protein was determined based on the cleavage of Ac-DEVD-AFC (3 mg/mL) to AFC. 
Values are expressed as mean ± SEM (n = 3–4). *P < 0.05 compared to control.
Discussion
To date, there have been few studies assessing the effects of 
both ethanol and betaine on oxidative damage and apoptosis 
in adolescents. Therefore, we investigated how ethanol affects 
juvenile hepatic cells through changes in oxidative damage, 
apoptosis, and liver function, and whether supplementation 
of betaine can provide protection or minimize the effects of 
oxidative liver injury.
The administration of ethanol caused a rise in the levels 
of hepatic enzymes, indicating structural membrane damage 
to the hepatocytes. Betaine was unable to prevent the rise in 
ALT levels following ethanol exposure (Table 2), although, 
it is perhaps the length of betaine treatment or concomitant 
betaine treatment that is essential for protection. In animal 
studies, prolonged betaine treatment has been shown to be 
efficacious in ameliorating the adverse effects of acute etha-
nol or lipopolysaccharide challenge (19, 20, 29, 30). Ethanol 
also led to a slight decrease in protein synthesis as measured 
by albumin, which may be due to perturbed elongation fac-
tors reducing protein translation (31). Pretreatment with 
betaine normalized protein and albumin levels (Table 2), 
which is consistent with previous findings (32).
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Figure 2. The effect of betaine on ethanol-induced changes in (A) cytosolic GSH levels, (B) mitochondrial GSH levels, (C) cyto-
solic MDA formation, and (D) mitochondrial MDA formation. The “betaine” experimental animals were given drinking water 
containing 2% betaine (w/v) for 6 days. Saline (0.15 mol/L NaCl) or ethanol (75 mmol/kg bodyweight) was administered i.p. on 
day 7, and 24 h later the animals were sacrificed. Liver mitochondrial and cytosolic fractions were prepared as described in the 
methods. Values are expressed as mean ± SEM (n = 3–4). *P < 0.05 compared to control.
Cytochrome c levels were significantly raised in the cyto-
plasm following ethanol treatment, and the levels were con-
sequently decreased in the mitochondria. Destabilization of 
the cardiolipin anchor may have occurred due to oxidative 
stress releasing cytochrome c into the cytosol. Betaine pre-
treatment maintained the levels of mitochondrial cytochrome 
c and reduced the release of cytochrome c into the cytosol 
(Figure 1). Betaine prevents adenosine-induced apoptosis by 
preventing increases in intracellular S-Adenosylmethionine 
(SAM) levels in rat hepatocytes (21). SAM supplementation 
has also shown to protect against apoptosis in rat hepatocytes 
after 24-h incubation with ethanol  (33). This suggests that 
induction of the methionine-homocysteine recycling mecha-
nism reduces cytochrome c release, which may in part be medi-
ated by oxidative stress. However, this did not translate into 
an increase in caspase-3 activity, which is an ATP- dependent 
activation step (34). Since ATP levels drop following ethanol 
metabolism (35–37) or can be depleted following 24-h starva-
tion (38) in conjunction with oxidative damage (39, 40), this 
may explain the lack of caspase 3 activity.
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Figure 3: The effect of betaine on ethanol-induced changes in (A) cytosolic GPx activity, (B) mitochondrial GPx activity, 
(C) cytosolic GSH reductase activity, and (D) mitochondrial GSH reductase activity. Following treatment, liver mitochondrial 
and cytosolic fractions were prepared as previously described, and the antioxidant enzyme activity was determined as described 
in the methods. Values are expressed as mean ± SEM (n = 3–4). *P < 0.05 compared to control.
Ethanol reduces the level of GSH (41–43); however, in our 
studies, cytosolic and mitochondrial GSH levels were gener-
ally maintained or slightly increased (Figure 2), and MDA 
levels were generally correspondingly decreased (Figure  2). 
These findings suggest that compensatory mechanisms 
are involved in preventing oxidative damage in response to 
acute ethanol administration (42, 44). This may be due to 
an increased synthesis of GSH in the cytoplasm along with 
its subsequent import to the mitochondria or increased syn-
thesis of antioxidant enzymes. This shows that the liver can 
respond to an acute ethanol dose and that the increased GSH 
production offers protection against basal oxidative damage.
Cytosolic GSH levels were only slightly reduced with beta-
ine and ethanol treatments (Figure 2), which may explain the 
corresponding lower cytosolic MDA levels, indicating that 
betaine is conferring some protection, perhaps via utilization 
of cytosolic GSH. A similar pattern was also observed in the 
mitochondria. The ameliorative effect of betaine on hepatic 
GSH and MDA levels has been shown in both acute and 
chronic models of ethanol intake (19, 20). Our data support 
Petagine L et al.












































































































































Figure 4: The effect of betaine on ethanol-induced changes in (A) cytosolic SOD activity, (B) mitochondrial SOD, (C) catalase 
activity, and (D) complex I activity. Following treatment, liver mitochondrial and cytosolic fractions were prepared as previously 
described and the antioxidant enzyme activity was determined as described in the methods. Values are expressed as mean ± SEM 
(n = 3–4).
the protective effects of betaine on GSH levels; however, the 
mechanism causing the increase remains to be elicited.
Ethanol consumption affects mitochondrial morphol-
ogy, which alters the capacity of oxidative phosphorylation 
(18,  45). Chronic treatment of ethanol induces loss of oxi-
dation phosphorylation proteins, which can be prevented by 
betaine supplementation (15). However, here we found com-
plex I activity increased after both acute ethanol treatment 
and ethanol and betaine combined treatment. Further stud-
ies are required to explore this finding.
Chronic ethanol treatment leads to decreases in both 
cytosolic and mitochondrial GPx (46). Concordantly, we 
demonstrated acute ethanol exposure led to a significant 
decrease in GPx activity in the cytoplasm as well as in the 
betaine-treated groups, indicating decreased clearance of 
H2O2. GPx and catalase activity remained unchanged in the 
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mitochondria across all treatment groups. Treatment with 
ethanol alone and treatment with both ethanol and betaine 
led to decreased SOD activity. The reduction in SOD activity 
may be due to ROS-induced enzyme degradation as well as a 
reduced synthesis of enzymes (47). However, as SOD activ-
ity increased in the cytoplasm with betaine treatment alone, 
betaine may provide some protection to oxidative damage via 
an increase in antioxidant enzymes. This demonstrates that 
the antioxidant enzymes are generally maintained after acute 
ethanol treatment in juvenile rats. Antioxidant enzymes are 
reduced with age and ethanol consumption (48–50), which 
may account for the higher antioxidant capacity in juvenile 
rats.
Conclusion
We have demonstrated that the livers from juvenile rats 
react differently to aged animals in response to acute etha-
nol by increasing GSH levels. Whilst the mechanism remains 
unclear, increasing GSH levels following acute ethanol could 
be due to higher basal levels and the capacity of antioxidant 
enzymes in adolescents. Betaine pretreatment was able to 
ameliorate or prevent some oxidative changes. Thus, betaine 
may serve as an effective therapeutic in the treatment of liver 
disease, as well as other diseases associated with oxidative 
damage.
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report: Substance use among students in 36 European coun-
tries. The Swedish Council for Information on Alcohol and 
other Drugs. 2012. http://www.can.se/PageFiles/2619/The_2011_
ESPAD_Report_FULL.pdf?epslanguage=sv
4. Hibell B, Andersson B, Bjarnason T, Ahlström S, Balakireva O, 
Kokkevi A, et al. The ESPAD report 2003: Alcohol and other 
drug use among students in 35 European countries. The Swedish 
Council for Information on Alcohol and other Drugs. 2004.
5. Clark Goings T, Salas-Wright CP, Belgrave FZ, Nelson EJ, 
Harezlak J, Vaughn MG. Trends in binge drinking and alco-
hol abstention among adolescents in the US, 2002–2016. Drug 
Alcohol Depend. 2019;200:115–123. http://dx.doi.org/10.1016/j.
drugalcdep.2019.02.034
Petagine L et al.
 Journal of Renal and Hepatic Disorders 2021;5(1): 19–29 28
Biochem Biophys Res Commun. 2008;368:893–8. http://dx.doi.
org/10.1016/j.bbrc.2008.02.003
20. Balkan J, Öztezcan S, Küçük M, Çevikbaş U, Koçak-Toker N, 
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